Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
BPC-157 for 46 weeks or longer if needed 3
It is studied as an inhibitor of nicotinamide N-methyltransferase
A large clinical trial was called for in the primary healthcare setting, where a high percentage of patients with vitamin B12 deficiency is seen
However, it is available in research settings and wellness clinics, where it is often marketed as an experimental peptide for fat loss and metabolic enhancement
Unlike EPO, ARA-290 is non-hematopoietic, meaning it does not stimulate red blood cell production
US$ 29.27
US$ 20.15
US$ 28.45
US$ 25.26
